Indication
Beta Lactam Resistant Bacterial Infection
2 clinical trials
3 products
Clinical trial
Piperacillin Tazobactam Versus Meropenem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae- a Non-inferiority Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2026-01-01
Product
Piperacillin/tazobactamProduct
MeropenemClinical trial
PipEracillin/Tazobactam vs mERoPENem for Treatment of AmpC-producing Bloodstream Infections: an Extension of the Original PETERPEN TrialStatus: , Estimated PCD: 2028-04-15
Product
Piperacillin / Tazobactam